Moreover, the elevated levels of miR-138-5p in the serum exosomes of breast cancer patients were positively associated with later stages, while the tissue expression of its target, KDM6B, was significantly lower in cancer patients than in normal controls [84]. The gene discussed is KDM6B; the disease is breast carcinoma.